ISD-Immunotech
Copenhagen
About ISD-Immunotech
ISD-Immunotech develops a first-in-class therapy to treat the most severe Systemic lupus erythematosus (SLE) patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Jul 2020)
- Website: isd-immunotech.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/isd-immunotech-509149 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.